NCT03782142View on ClinicalTrials.gov

Effect on HIV Medications on EPC Cells

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

November 12, 2020

Study Completion Date

December 14, 2021

Conditions
AIDS
Interventions
DRUG

Tenofovir

TAF (tenofovir alafenamide) or TDF(tenofovir disoproxil fumarate)

DRUG

Rilpivirine

NNRTI

DRUG

Prezcobix

PI

DRUG

Dolutegravir

II

Trial Locations (1)

20037

The GW Medical Faculty Associates, Washington D.C.

All Listed Sponsors
lead

Sabyasachi Sen

OTHER

NCT03782142 - Effect on HIV Medications on EPC Cells | Biotech Hunter | Biotech Hunter